wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35025461-16734950-4E15-46C8-B951-F696DDFDDF08
Q35025461-16734950-4E15-46C8-B951-F696DDFDDF08
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35025461-16734950-4E15-46C8-B951-F696DDFDDF08
Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells.
P2860
Q35025461-16734950-4E15-46C8-B951-F696DDFDDF08
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35025461-16734950-4E15-46C8-B951-F696DDFDDF08
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c0beb96cf5c4f236964d1b41668706faedc90b27
P2860
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure